Tilray Brands (NASDAQ: TLRY) is focused on expanding its reach. The marijuana company has now branched out to include CBD products and alcohol, and has started to call itself "a global lifestyle and consumer packaged goods company." It's not a bad idea, given the headwinds in the marijuana space, but there are material risks to consider here. The marijuana market hasn't panned out as hoped The first big problem with Tilray Brands isn't actually specific to the company. It is a problem that the entire mar ...

Core Viewpoint - cbdMD, Inc. (YCBD) is demonstrating steady growth and improving financial health through strategic initiatives and disciplined cost management [1][2][5] Financial Performance - YCBD reported revenue of approximately $4.72 million for the period, slightly above the estimated $4.70 million, indicating steady growth [2][5] - The company has significantly reduced its operating loss to $2.1 million, an improvement from the $3.3 million loss in fiscal 2024, attributed to disciplined cost management and investments in quality and science [2][5] Financial Position - YCBD has strengthened its financial position through a $2.25 million Series C Preferred Stock private placement, with approximately $2.1 million available for working capital and strategic initiatives after expenses [3] - The Series C shares offer a 10% annual dividend and conversion options, providing flexibility for investors [3] - The company maintains a low debt-to-equity ratio of 0.16, indicating modest debt levels, and a current ratio of 1.56, suggesting good liquidity to cover short-term liabilities [4]